BRAF; cyclin dependent kinase inhibitor 2A (CDKN2A; INK4a; ARF; p16INK4a); cyclin dependent kinase 4 (CDK4); CDK6 BriefCommunication Pages: 540 - 540
Phosphatidylinositol-3,4,5-triphosphate-dependent Rac exchange factor 2 (PREX2) BriefCommunication Pages: 547 - 547
High throughput screening of T cell receptor (TCR) to detect minimal residual disease (MRD) in T cell acute lymphoblastic leukemia (T-ALL) BriefCommunication Pages: 560 - 560
Proteomic method for developing rational combinations of kinase inhibitors BriefCommunication Pages: 561 - 561
Protocol for augmenting β cell regeneration and reversing late-stage type 1 diabetes BriefCommunication Pages: 563 - 563